7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hemarthrosis D006395 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Tooth Mobility D014086 2 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Hip Dislocation D006617 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Coronary Stenosis D023921 6 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Bacteremia D016470 9 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Gingival Recession D005889 2 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hashimoto Disease D050031 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Arthralgia D018771 8 associated lipids
Osteophyte D054850 2 associated lipids
Hemophilia A D006467 10 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Encephalitis D004660 15 associated lipids
Macular Degeneration D008268 5 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Actinomycosis D000196 2 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Angina, Stable D060050 2 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Respirovirus Infections D010253 3 associated lipids
Thinness D013851 11 associated lipids
Obesity, Morbid D009767 8 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Tooth Migration D014085 2 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Tinnitus D014012 4 associated lipids
Cherubism D002636 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Labyrinthitis D007762 2 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foot Injuries D018409 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Rheumatic Fever D012213 1 associated lipids
Progeria D011371 3 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Periostitis D010522 1 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Venous Thrombosis D020246 11 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Microvascular Angina D017566 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Chronic Disease D002908 7 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Carcinosarcoma D002296 7 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Akiyama N et al. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. 2014 J. Exp. Med. pmid:25385757
Lv Y et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. 2014 BMC Musculoskelet Disord pmid:25377946
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Bandeira F et al. Bone markers and osteoporosis therapy. 2014 Arq Bras Endocrinol Metabol pmid:25166041
Foo JP et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. 2014 J. Clin. Endocrinol. Metab. pmid:25148234
Warren JT et al. Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. 2014 Sci Signal pmid:25140055
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
Marques EA et al. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. 2013 Sep-Oct Arch Gerontol Geriatr pmid:23623588
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Canto-Cetina T et al. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. 2013 Nov-Dec Am. J. Hum. Biol. pmid:24130145
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Zamora PO et al. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. 2013 Mar-Apr Int. J. Toxicol. pmid:23422080
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Nanjundaiah SM et al. Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. 2013 Jan-Mar Int J Immunopathol Pharmacol pmid:23527707
Scholtysek C et al. PPARβ/δ governs Wnt signaling and bone turnover. 2013 Nat. Med. pmid:23542786
Stuss M et al. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2013 J. Clin. Endocrinol. Metab. pmid:23543663
Winther S et al. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease. 2013 Clin. Nephrol. pmid:23547804
Peng X et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. 2013 PLoS ONE pmid:23516466
Umesan UK et al. Assessing salivary biomarkers for analyzing orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23561400
Flórez-Moreno GA et al. Authors' response. 2013 Am J Orthod Dentofacial Orthop pmid:23561401
Lu L et al. A novel therapeutic strategy for adolescent idiopathic scoliosis based on osteoporotic concept. 2013 Med. Hypotheses pmid:23562283
Fu YX et al. Osteoprotegerin influences the bone resorption activity of osteoclasts. 2013 Int. J. Mol. Med. pmid:23563320
Xu L et al. Effects of cell surface α2-3 sialic acid on osteogenesis. 2013 Glycoconj. J. pmid:23519914
Kwon H et al. Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. 2013 Lasers Med Sci pmid:22699799
Løgstrup BB et al. Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction. 2013 Coron. Artery Dis. pmid:23777975
Zhang Y et al. Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis. 2013 Clinics (Sao Paulo) pmid:23778340
Liu M et al. Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. 2013 BMC Complement Altern Med pmid:23782721
Shen Q et al. Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats. 2013 J. Pharm. Pharmacol. pmid:23738728
Takeuchi S et al. Acidosis inhibits mineralization in human osteoblasts. 2013 Calcif. Tissue Int. pmid:23754489
Antonoglou G et al. Serum osteoprotegerin and periodontal destruction in subjects with type 1 diabetes mellitus. 2013 J. Clin. Periodontol. pmid:23758409
Pateinakis P et al. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. 2013 BMC Nephrol pmid:23758931
Weiss RM et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. 2013 PLoS ONE pmid:23762316
Pichler K et al. Towards a better understanding of bone bridge formation in the growth plate - an immunohistochemical approach. 2013 Connect. Tissue Res. pmid:23941205
Liao C and Hua Y Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation. 2013 Arch. Oral Biol. pmid:24200305
Fontes JD et al. Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. 2013 Atherosclerosis pmid:23489346
Oliver JL et al. Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. 2013 Pigment Cell Melanoma Res pmid:23490134
Mankoč Ramuš S et al. SNP rs2073618 of the osteoprotegerin gene is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes. 2013 Biomed Res Int pmid:24228244
Maïmoun L et al. Peripubertal female athletes in high-impact sports show improved bone mass acquisition and bone geometry. 2013 Metab. Clin. Exp. pmid:23490587
Stalvey MS et al. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. 2013 PLoS ONE pmid:24236172
Zhou J et al. [Effect of osthole on bone metabolism in rat femoral tissues in vitro]. 2013 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:24183047
Jacobs C et al. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain. 2013 Arch. Oral Biol. pmid:23422327
Joo MK et al. The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. 2013 Mol Med Rep pmid:23426758
Tecilazich F et al. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. 2013 J. Vasc. Surg. pmid:23465172
Wei CC et al. Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis. 2013 BMC Complement Altern Med pmid:23870279
Cao H et al. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. 2013 Ann. Thorac. Surg. pmid:23870696
Xu F et al. Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. 2013 Mol Med Rep pmid:23835909
Dahl JS et al. Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. 2013 Am. J. Cardiol. pmid:23871267
Zhu J et al. The influence of g.19124G>a genetic polymorphism in the OPG gene on bone mineral density in Chinese women. 2013 Genet Test Mol Biomarkers pmid:23837846
Salbach-Hirsch J et al. The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. 2013 Biomaterials pmid:23871544
Zhou S et al. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. 2013 PLoS ONE pmid:23874840
Araújo AA et al. Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model. 2013 J. Clin. Periodontol. pmid:24118063
Meneghini M et al. Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. 2013 Transplantation pmid:23812001
Bao X et al. The effect on proliferation and differentiation of cementoblast by using sclerostin as inhibitor. 2013 Int J Mol Sci pmid:24152444
Prati AJ et al. Release of bone markers in immediately loaded and nonloaded dental implants: a randomized clinical trial. 2013 J. Dent. Res. pmid:24158337
de Araújo Júnior RF et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. 2013 PLoS ONE pmid:23843954
Kim HR et al. Serum osteoprotegerin level is associated with degree of arteriovenous fistula stenosis in patients with hemodialysis. 2013 Clin. Nephrol. pmid:24091316
Xiong Q et al. [Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors]. 2013 Zhongguo Gu Shang pmid:23844495
Zhang PF et al. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis. 2013 COPD pmid:23845033
Di Bartolo BA et al. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. 2013 PLoS ONE pmid:24040204
Zong ming W et al. Bone formation in rabbit cancellous bone explant culture model is enhanced by mechanical load. 2013 Biomed Eng Online pmid:23597232
LaCroix AZ et al. OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study. 2013 Bone pmid:23735608
Napimoga MH et al. Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. 2013 Int. Immunopharmacol. pmid:23597428
Wulf-Johansson H et al. Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions. 2013 PLoS ONE pmid:24349233
Bradaschia-Correa V et al. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats. 2013 Cell Tissue Res. pmid:23636419
Nehring P et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. 2013 Pol. Arch. Med. Wewn. pmid:23299915
Chandran V et al. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. 2013 J. Rheumatol. pmid:23637322
Kaludjerovic J and Ward WE Adequate but not supplemental folic acid combined with soy isoflavones during early life improves bone health at adulthood in male mice. 2013 J. Nutr. Biochem. pmid:23643520
Kim JY et al. Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress. 2013 Arthritis Rheum. pmid:23666878
Marano RJ et al. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. 2013 PLoS ONE pmid:23667691
Galeone A et al. Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 2013 Eur J Cardiothorac Surg pmid:23671202
Wang Q et al. [Effects of treadmill exercise on mRNA expression levels of osteoprotegerin, RANKL and RUNX2 in bone tissues of ovariectomized]. 2013 Zhongguo Gu Shang pmid:24605748
Matsuo K [Osteoimmunologic regulation of aging]. 2013 Clin Calcium pmid:23268303
Ming LG et al. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. 2013 Endocrinology pmid:23389955
Piatek S et al. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis. 2013 Maturitas pmid:23391500
Biscetti F et al. Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. 2013 Hum. Genet. pmid:22965192
Hemingway F et al. Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT. 2013 Exp. Mol. Pathol. pmid:23391709
Kuriwaka-Kido R et al. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. 2013 Endocrinology pmid:23397032
Manfrin TM et al. Expression of OPG, RANK, and RANKL proteins in tooth repair processes after immediate and delayed tooth. 2013 J Craniofac Surg pmid:23348347
Zhou J et al. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats. 2013 Rheumatol. Int. pmid:22948539
Saito K et al. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. 2013 PLoS ONE pmid:23349978
Keller KK et al. SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes. 2013 Rheumatol. Int. pmid:22948540
Kelesidis T et al. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. 2013 AIDS Res. Hum. Retroviruses pmid:23351153
Chen X et al. Environmental level of cadmium exposure stimulates osteoclasts formation in male rats. 2013 Food Chem. Toxicol. pmid:23954550
Malik P et al. Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. 2013 Prog. Neuropsychopharmacol. Biol. Psychiatry pmid:23380173
Pereira GB et al. Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome. 2013 Clin Physiol Funct Imaging pmid:23383690
Benslimane-Ahmim Z et al. Mechanistic study of the proangiogenic effect of osteoprotegerin. 2013 Angiogenesis pmid:23386104
Cody JJ et al. Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. 2013 Lab. Invest. pmid:23358109
Belaya ZE et al. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. 2013 Osteoporos Int pmid:23358608
Pei Z et al. Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells. 2013 Mol Med Rep pmid:24065204
Pamuk BO et al. Evaluation of circulating endothelial biomarkers in familial Mediterranean fever. 2013 Rheumatol. Int. pmid:23358733
Ney JT et al. Genetic polymorphism of the OPG gene associated with breast cancer. 2013 BMC Cancer pmid:23369128
Milone F et al. Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. 2013 Biomarkers pmid:23336103
Cao H et al. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. 2013 Int. J. Cardiol. pmid:22178057
Grant M et al. Induction of cytokines, MMP9, TIMPs, RANKL and OPG during orthodontic tooth movement. 2013 Eur J Orthod pmid:22987319
Wang Y et al. The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation. 2013 Biomaterials pmid:23079666
Sottnik JL and Keller ET Understanding and targeting osteoclastic activity in prostate cancer bone metastases. 2013 Curr. Mol. Med. pmid:23061677
Kerschan-Schindl K Bone turnover in hyperparathyroidism. 2013 Wien Med Wochenschr pmid:22805761

Table of Content